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1. Introduction 
Major depression and alcohol dependence are two of the most prevalent psychiatric 
disorders affecting the general population, resulting in significant consequences to society at 
large, including lost productivity, health care demands, psychosocial disruption, and even 
increased mortality rates [1]. Recent research suggests that excessive alcohol use and 
depression account for an estimated $223.5 billion and $83.1 billion, respectively, in 
economic costs to the United States alone [2,3]. In addition, prevalence rates of co-morbidity 
between alcohol dependence and depression are rising; 12-month prevalence rates of 
alcohol dependence among individuals with a 12-month Diagnostic and Statistical Manual of 
Mental Disorders, Fourth Edition, Text Revision [4] diagnosis of major depression and 
dysthymia were 11.03% and 9.62%, respectively [5]. As a result of the deleterious 
psychological impact on the individual and the economic burden on society, there is a 
growing interest in increasing understanding of the co-occurrence of alcohol dependence 
and major depression, and development and implementation of effective treatments for 
these significant and prevalent disorders.  
Multiple empirically supported behavioral treatments exist to treat chronic depression and 
alcohol dependence separately, but there is less research examining concomitant or 
integrated treatment for co-occurring chronic depression and alcohol dependence. Although 
there has been a modicum of research regarding the etiology, relationships, and treatment of 
chronic depression and alcoholism, the specific common mechanisms and effective 
treatments have been elusive. Of note, the majority of so-called “third wave” cognitive 
behavioral therapies have not yet been rigorously studied for this specific population of 
chronically depressed alcohol dependent individuals. Specifically, Cognitive Behavioral 
Analysis System of Psychotherapy (CBASP) has demonstrated effectiveness in treating 
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chronic depression [6,7], but has not yet been studied in a large trial with persons with co-
occurring alcohol dependence and chronic depression. Therefore, the purpose of this 
chapter is to discuss the therapeutic model of CBASP and the rationale for its proposed use 
in treating chronic depression and alcohol dependence concurrently. The paper begins with 
a description of the characteristics of persons who suffer from chronic depression and 
alcohol dependence and how these characteristics contribute to a challenging therapeutic 
scenario. Theories behind the co-morbid development of the two disorders are then 
presented, followed by a brief review of the literature regarding treatment for co-occurring 
depression and substance use. The therapeutic model of CBASP and its adaptation for 
treating co-occurring disorders is then discussed. Finally, the paper concludes with the 
introduction of an ongoing research study using CBASP to treat chronic depression and 
alcohol dependence simultaneously. 
2. Characteristics of Chronically Depressed Alcohol Dependent (CDAD) 
individuals and treatment challenges 
Chronically depressed alcohol dependent (CDAD) individuals possess unique 
characteristics, especially when compared to depressed-only individuals, and these 
characteristics present unique challenges for the therapist and for therapy. CDAD patients 
are often younger at their first psychiatric hospitalization, have experienced a greater 
number of major depressive episodes and suicide attempts, and have poorer physical and 
psychiatric outcomes [8,9]. Untreated alcoholism can exaggerate depressive states and 
enhance the chances of self-destructive behaviors, suicide attempts, and even suicide [10]. 
Thus, there is a greater possibility of early death in CDAD individuals. Individuals who 
suffer from co-occurring alcohol dependence and major depression are also more likely to 
relapse and prematurely dropout of treatment [8].  Individuals with CDAD typically report 
a high rate of adverse early home environments, a lifelong history of intrapersonal and 
interpersonal failure, and an earlier onset of disorders. They have higher rates of 
comorbidities, a more severe course of illness, and they demonstrate a predominant 
interpersonal style of avoidance and detachment [9,11,12].  Early abuse or trauma history 
impairs development of adequate interpersonal coping skills, resulting in depression, social 
isolation, or withdrawal for many in this population [13]. In addition, real-world and 
prolonged environmental stressors usually accompany CDAD individuals’ presenting 
complaints. They are often skeptical or ambivalent about change, and the processes of 
change are often slow, irregular, and inconsistent. In fact, a pattern of success followed by a 
setback is common and periodic plateaus in progress occur. 
Research suggests that poor treatment outcomes for CDAD individuals occur, in part, due to 
these complex characteristics which these individuals possess that make their treatment 
more challenging [9,10,14,15]. Chances of poor outcomes increase among individuals who 
(a) are diagnosed with both depression and alcohol dependence, compared to those 
diagnosed with a single disorder [10,14]; and (b) suffer from major depression during and/or 
after treatment of alcohol dependence. This second aspect is important because depressed 
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mood has been found to be an important trigger for alcohol relapse [5,14]  Importantly, 
there is some evidence [16] that early intervention for alcohol dependence may improve not 
only problems with alcohol but also mood. 
Challenges to treatment are numerous and the CBASP therapist must possess specific skills 
to be successful in administering therapy to this population. The CDAD patient may be 
ambivalent about changing either or both of the symptoms of alcoholism and/or depression 
and motivation for change is typically low for these patients, as is hope for the future. As 
stated, the processes of change are slow and irregular. The patient is typically 
interpersonally avoidant, and may lack effective interpersonal communication skills as well 
as problem-solving and coping skills. They may use alcohol as a maladaptive coping 
strategy, placing themselves at risk for alcohol-related injuries and negative consequences.  
Thus the therapist must possess skills to help clarify the patient’s ambivalence and increase 
motivation to change. These are the same skills a therapist may use in motivational 
enhancement therapies or motivational interviewing. In addition, the therapist must be 
patient and empathic, with an ability to be genuine and respond in a way that is judicious 
and self-disciplined. It is helpful if the therapist is aware of his or her own transference 
hypotheses and appreciative of his/her own interpersonal impact on others. Acquisition of 
such knowledge is formalized and is typically part of the required training for CBASP 
therapists. Such training and knowledge is conceptualized as crucial in helping CBASP 
therapists gain insight into their own interpersonal pulls and pitfalls that could 
inadvertently sabotage the therapeutic process and/or promote burnout in the therapist. 
3. Theoretical explanations for co-morbid major depression and alcohol 
dependence 
The co-morbidity of chronic depression and alcohol dependence is prevalent and 
debilitating and warrants significant investigation regarding what predisposes the co-
occurrence of these disorders. Research has found CDAD individuals to have several 
predisposing factors that increase the likelihood of experiencing co-morbid major 
depression and alcohol dependence. Research on twin studies suggests a shared genetic risk 
factor for depression and alcoholism, and recent findings suggest an association between the 
CLOCK gene and the co-morbid condition of alcohol misuse and depressive disorders. 
[17,18]. Data also supply evidence of overlapping neuroanatomical correlates for both 
disorders. For example, regions of the brain such as the ventromedial prefrontal cortex 
which are important for homeostasis, emotional regulation, and decision making, show 
dysfunction in both depression and alcohol dependence [19,20].  Other areas of the brain, 
such as the dorsolateral prefrontal cortex, the amygdala, and the insula have been reported 
to be important in both depression and alcohol dependence [21]. 
There are also psychological and behavioral correlates similar in both disorders. Brewer et 
al. [21] review the role of rumination and stress, which are both commonly seen in these two 
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disorders. They conclude that depression and substance use disorders including alcoholism, 
share several phenotypes such as stress vulnerability and rumination, which suggests 
possible mutual underlying neurobiological dysfunction. There is also evidence to support 
the claim that early childhood trauma plays an important role in comorbidity between the 
two disorders. Common scenarios reported by CDAD individuals include an early 
victimization or trauma (e.g., death of a loved one, parental divorce or separation, physical 
or sexual abuse) that leads to major depression and subsequent alcohol abuse, or 
experiencing negative consequences from abusing alcohol that leads to major depression 
[22]. Both scenarios are related to a third predisposing factor – that is, CDAD individuals 
have ineffective internal mechanisms to cope with negative psychological symptoms, such 
as depressive symptoms. As a result, CDAD individuals learn to use alcohol to alleviate 
depressive affect (e.g., via modeling or operant conditioning), a theory known as self-
medication. In effect, individuals who suffer from major depression are at an increased risk 
for alcohol dependence and relapse [23]. 
Finally, Merrill and Read [24] have assessed multiple pathways leading to alcohol drinking. 
They found a difference between individuals who drink to cope and specific problem 
domains. In their study, individuals who used alcohol as a way to cope with negative affect 
also had a direct association with academic/occupational difficulties and risky behaviors, as 
well as poor self-care. Nelson, Little, Heath, and Kessler [25] noticed that when role 
impairment and poor self-care in individuals who consume alcohol is present, it predicts 
future progression to more severe symptoms such as dependence. Thus, those individuals 
who drink and display negative affect and depressive symptoms may be at additional risk 
for an increased severity of disease. 
4. Treatment of co-occurring depression and substance related problems: 
A comparison of approaches 
The shared characteristics and etiological underpinnings of two of the more prevalent forms 
of psychopathology have resulted in an increased interest in the co-occurrence of these 
disorders. Despite the recognition of a need for an integrated treatment approach for mood 
disorders and substance abuse – and chronic depression and alcohol dependence more 
specifically – empirical examination of such interventions is limited. Data from The National 
Survey on Drug Use and Health indicate that of adults experiencing co-occurring significant 
psychological distress and a substance use disorder, a majority did not receive treatment for 
either disorder [26]. Only approximately 12% were treated for both disorders. This shortfall 
is likely the result of a lack of availability of empirically supported integrated treatments for 
comorbidities of this type. 
While there are currently multiple empirically supported behavioral treatments for 
depression and alcoholism as individual disorders, knowledge about effective integrated 
treatment options is far from complete. Carroll [8] and others [27,28] acknowledge that there 
have been few well-specified behavioral therapies with an integrated approach (versus 
parallel) to treating symptoms of both disorders. Integrated treatment models are those in 
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which treatment for both the mood disorder and the substance use disorder is delivered at 
the same time, in the same program, by the same staff. This is in contrast to sequential 
treatment where the addiction is treated prior to the depression, or parallel treatment, in 
which patients are treated for mental illness in one system and for the substance use 
disorder in another [29].  
Carroll [8] reviewed the most common evaluated types of behavioral therapies for co-
occurring disorders and included cognitive behavioral therapy (CBT), motivational 
interviewing (MI), and contingency management (CM). Cognitive behavioral therapy (CBT) 
and coping skills strategies have been shown to be effective across a wide range of substance 
use and psychiatric disorders, including alcohol dependence and depression [30-32], but 
controlled trials for co-occurring alcoholism and depression are limited, both in supply and 
design. In a qualitative review, Hides and colleagues [33] concluded that while CBT is more 
efficacious than no treatment control conditions, there is limited evidence to suggest that 
CBT is better suited for treating co-occurring depression and substance use compared to 
other psychotherapeutic interventions. In part, they site poor heterogeneity between existing 
studies as a key reason why the evidence is inconclusive. 
Conversely, a more recent quantitative review of the literature highlights the effectiveness of 
CBT to reduce depressive symptoms and alcohol use [34]. In one study a moderate effect on 
alcohol use and/or depressive symptoms with Cognitive Behavior Therapy- Depression 
(CBT-D) was demonstrated, but included only patients with elevated depression (Beck 
Depression Inventory ≥ 10), not diagnosed depressive disorders [14]. Another study found 
that adding CBT-D for alcoholics with significant depressive symptoms was more effective 
on mood and alcohol use measures than standard treatment alone within an individual, but 
not a group treatment modality [35]. However, it is possible that treatment effects were due 
to the added therapist contact in the individual condition. 
More systematic investigations have also been conducted in recent years. One randomized 
clinical trial compared the effectiveness of computer versus therapist delivered CBT with MI 
components [36]. All patients had comorbid depression with substance misuse, a substantial 
portion of which was alcohol misuse, and each received a single session of integrated 
CBT/MI before being randomized to a no treatment control condition, or nine sessions of 
CBT/MI delivered by a psychotherapist or a computer. As hypothesized, treatment 
conditions were associated with significant reductions in alcohol use and symptoms of 
depression, with long-term intervention having a greater impact. A similar RCT performed 
by Baker and colleagues [37] sought to determine the effectiveness of CBT/MI that is single-
focused or integrated. Results found integrated treatment to be associated with greater 
improvement in alcohol use as well as depressive symptoms when compared to single-focus 
interventions. Similar support has been found in adolescent samples, which highlight 
treatment gains even at two years post-treatment [38]. 
Although there is good empirical support for the effectiveness of MI in substance use 
disorders and related behavioral domains [39-41], well-controlled evaluations of MI as a 
stand-alone treatment or MI adapted for co-occurring disorders are rare, and demonstrate 
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improvements in treatment engagement/retention, motivation, and satisfaction, but not 
improvements in mood or decreased substance use [42-44]. In one small sample study (N = 
5), MI was integrated with CBT for bipolar patients with comorbid substance use [45]. 
Modest reductions in both mood symptoms and substance use were observed. 
Contingency Management (CM) has demonstrated more robust findings when used in 
depressed cocaine addicted populations [46,47]. In a pilot study which employed an 
integrated CM approach, opioid dependent patients experienced decreases in depressive 
symptoms, but decreases in usage were not significant. However, it has not been 
implemented with CDAD individuals and CM is not always logistically or financially 
feasible. 
In addition to those interventions highlighted by Carroll [8], mindfulness training (MT) and 
behavioral activation have seen more limited attention in the treatment of co-occurring 
disorders. Brewer and colleagues [21] reviewed the evidence for a shared mechanism in 
depression and substance abuse that might allow MT to reduce substance use and improve 
psychiatric symptoms. Another treatment study focused on inner-city substance users with 
mild to moderate depression and found that a modified version of behavioral activation was 
successful at reducing depressive symptoms of patients during residential substance abuse 
treatment [48]. Interpersonal psychotherapy has also seen moderate support in the 
reduction of depressive symptoms, but less so for days abstinent from alcohol with the 
converse being the case for brief supportive therapy [49]. Another study comparing 
integrated CBT with twelve-step facilitation (TSF) found both to be effective, with TSF 
producing slightly better improvements in depression and abstinence [50]. The 
aforementioned findings appear to support the hypothesis that an integrated therapy 
possessing components of motivational enhancement, cognitive and behavioral therapy, as 
well as management of reinforcements, would be most ideal when targeting co-occurring 
depression and alcoholism. 
5. CBASP for chronically depressed alcohol dependent individuals 
Despite the aforementioned similarities found among individuals dealing with chronic 
depression and alcohol dependence, investigation of more synthesized treatment 
approaches has occurred in a limited fashion. “Third wave” cognitive behavioral therapies 
represent one underexplored subset of treatment approaches. Specifically, the Cognitive 
Behavioral Analysis System of Psychotherapy (CBASP) [51, 52] has demonstrated 
effectiveness in treating chronic depression, demonstrating effects equal to antidepressant 
medications as well as enhancing the effects of pharmacotherapy [6,7]. CBASP has yet to be 
studied in a large trial with persons with co-occurring alcohol dependence and chronic 
depression. However, in a case report from clinical practice, CBASP has been effective in 
reducing symptoms of chronic depression and significantly reducing alcohol intake to 
healthy drinking levels in CDAD individuals [53]. CBASP is particularly proficient for use 
with the early onset variety of unipolar mood disorders. Its etiological premise is that 
chronic depression arises as a result of a developmental history characterized by significant 
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interpersonal trauma (e.g., physical/sexual abuse) or low grade, but continuous stream of 
psychological insults (e.g., punishment/rejection of some form); both lead to a 
preoperational form of thinking about one’s social world. This derailment is particularly 
characterized by a lack of causal awareness and egocentrism in the depressive patient. This 
often results in a presentation of poor functioning and/or low motivation for change [51]. 
Additionally, a lack of awareness for their interpersonal impact and poor interpersonal 
problem-solving skills is prevalent [51,52,54,55]. CBASP takes a person-by-environment 
perspective in modifying depressive symptoms by raising a patient’s awareness about their 
interpersonal impact on others [51,56,57]. This is done by highlighting the interpersonal 
interaction as it occurs in the therapeutic setting. Recognizing one’s own stimulus value in 
the interpersonal context allows the chronic depressive to amend how he or she presents 
and copes with stressful interpersonal situations. CBASP holds that the interpersonal fear 
that drives avoidance, the central theme in many interpersonal failures, must be counter-
conditioned. This is done by aiding the patient in discriminating their experience with the 
therapist, from those experiences with harmful significant others to create a sense of felt 
interpersonal safety that can then be generalized outside of the therapy setting [57]. 
Another major component of CBASP is Situational Analysis (SA). SA is an interpersonal 
problem-solving tool that is used in-session to help a patient actively re-experience an 
interpersonal encounter [51,56,57]. The goal of SA is to elicit the original cognitions and 
emotions during the target situation. This involves having the client first isolate an event, 
describe it in exclusively behavioral terms, and identify the situational outcome. The goal of 
this exercise is to help the client identify alternative ways of behaving and thinking that 
would lead to more desirable consequences. New ways of behaving interpersonally are 
often met with obtaining desirable outcomes, reinforcing effective problem-solving skills, 
and allowing the patient to perceive his or her contingent relationship with the 
environment. Through these means the patient may acquire “perceived functionality” – that 
is, the patient’s ability to recognize and begin to change the interpersonal consequences of 
their behavior. 
CBASP has demonstrated effectiveness in treating chronic depression, and is more effective 
than antidepressant monotherapy in individuals with early trauma or adversity [7,58-60]. 
Moreover, both the therapeutic relationship and the ability of the patient to learn SA 
effectively have been shown to independently contribute to a reduction in depressive 
symptoms [61]. Additionally, there is some evidence to support the notion that CBASP may 
be efficacious for individuals who do not respond to a trial of antidepressant medications 
initially [62]. CBASP has also been shown to outperform interpersonal psychotherapy in 
treating chronic depression [63], suggesting it may offer more when treating co-occurring 
chronic depression and alcoholism. Strong support for CBASP has been tempered by recent 
results [64], which found that neither CBASP nor Supportive psychotherapy was more 
effective than medication alone for chronically depressed treatment resistant patients. The 
lack of positive findings in that study were hypothesized to be related to the small number 
of CBASP sessions (mean = 12.5 sessions) and the effect of an aspect of the study design 
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which focused on pharmacological switching and augmentation that may have had a 
negative impact on patients’ interests in and expectations of, psychotherapy [65]. CBASP has 
been used to treat chronically depressed pregnant smokers and was found to be more 
effective than standard treatment at increasing abstinence and decreasing depressive 
symptoms six months post treatment. CBASP was more effective in women with higher 
levels of baseline depressive symptoms [66]. CBASP has also proven useful in a small 
sample study demonstrating that increases in positive affect and a decrease in depressive 
symptoms are associated with greater likelihood of prolonged abstinence from cigarette 
smoking [67]. 
6. Rationale for and adaptations of CBASP for CDAD individuals 
Those entering substance abuse treatment programs with co-occurring disorders report 
using multiple drugs, having more recent admissions to psychiatric and medical facilities, 
and experiencing more severe medical, social, and family problems compared to those 
diagnosed solely with a substance use disorder [23]. These characteristics are unique in 
nature, suggesting the need for specialized treatment addressing depression and alcoholism 
simultaneously. The Substance Abuse and Mental Health Services Administration (SAMSA) 
in the USA [26] has come to similar conclusions in their recommendations for Center for 
Substance Abuse Treatment (CSAT) treatment improvement protocols with co-occurring 
disorders, suggesting individualized, integrated dual primary diagnosis-specific treatment 
interventions matched to diagnoses, phase of recovery, stage of change, and severity. 
Interestingly, no studies have evaluated the use of a behavioral treatment approach that can 
address these specific mood and addiction symptoms that characterize the CDAD 
individual. 
CBASP is a behavioral treatment that addresses the unique characteristics of chronically 
depressed individuals, most of which are highly relevant for alcohol dependent individuals 
as well. CBASP is designed for persons who may (a) be less functional and less motivated to 
change; (b) have traumatic or impoverished developmental or reinforcement histories; and 
(c) lack awareness of their interpersonal impact or have poor interpersonal problem-solving 
skills. Thus, CBASP appears to be a plausible behavioral approach for use with CDAD 
individuals who may report traumatic developmental histories, manifest impoverished 
interpersonal relations, interactions and coping skills, and demonstrate additional chronic 
under-functioning [59,61,67]. Because of its structured but individualized and collaborative 
design, emphasis on teaching effective coping strategies, and employment of motivational, 
cognitive, behavioral, and interpersonal techniques, CBASP is uniquely suited for use in 
treating alcoholism in the context of chronic depression [7,67]. 
The major goals of CBASP are (a) to enable patients to feel increased emotional safety, thus 
allowing them to more fully approach and engage in treatment and reduce avoidance 
behavior, including drinking; and (b) to allow patients to recognize how they contribute to 
their own interpersonal psychopathology (perceived functionality) and begin to learn how 
to negotiate interpersonal situations successfully and without the use of alcohol. 
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Importantly, CBASP provides an empirical method to facilitate and measure exactly what 
and how much is being learned during the course of therapy [57]. Both felt emotional safety 
in the therapeutic dyad and learned acquisition of perceived functionality are hypothesized 
to be related to the outcome of treatment and, over time, to the maintenance of the 
therapeutic gains. These skills can be measured in multiple correlated ways, including 
evaluation of learning in session via achievement of therapeutic interpersonal tasks, 
performance on psychological tests of prediction of interpersonal response, and fMRI 
assessment of the neurobiological correlates of perceived functionality that have been 
identified in chronic depressives [68]. 
In sum, treatment for CDAD individuals must be targeted or personalized for the 
underlying interpersonal issues and skill deficits of the individual in order to be most 
effective. CBASP is a behavioral treatment which can be adapted to comprehensively 
address these issues and deficits to successfully treat both alcohol dependence and chronic 
depression simultaneously. 
7. Current research with CBASP to treat co-occurring chronic depression 
and alcohol dependence 
We have developed an enhanced integrative CBASP for use in reducing both depressive 
symptoms and alcohol intake in CDAD patients. The augmented CBASP includes all the 
aspects of traditional CBASP and adds coping skills training for reducing alcohol intake. One 
of the most important components of successfully conducting CBASP with this population is 
helping the patient discover the causal connections between their mood symptoms and 
drinking behavior and ultimately change the functional linkages between their depression and 
drinking. The drinking behavior is conceptualized as a maladaptive coping strategy that is 
often an outcome of interpersonal situations for this patient population. Drinking behavior is 
also conceived of as avoidance behavior, which interferes with learning and practicing 
effective interpersonal problem solving and coping. Further augmentations include additional 
assessment and monitoring of stage of change and motivation levels for both depressive 
symptoms and alcohol use. During the middle phase of treatment and in session after the 
Coping Survey Questionnaire (Situational Analysis) has been remediated, alcohol reduction 
coping skills are identified and taught in the same manner that traditional CBT is conducted. 
Significant adaptations for use with this population involve setting and assessing alcohol 
consumption goals in addition to depressive symptoms and quality of life/level of functioning 
goals for treatment. A harm reduction approach, similar to that utilized in CBT for alcohol 
dependence, is used to address alcohol consumption. Thus, patients do not need to be 
abstinent when in treatment and do not necessarily have to set abstinence as their goal, 
although it is preferred. The overall approach to symptom change is compatible with the 
CBASP essence of treatment, which allows the patient to establish how the therapy session will 
proceed and enables the patient to do the work of change. 
A twenty-session pilot study examining the use of our augmented CBASP for persons with 
co-occurring chronic depression and alcohol dependence is currently underway at the 
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University of Virginia School of Medicine in the Department of Psychiatry and 
Neurobehavioral Sciences in Charlottesville, Virginia. Sessions were individually 
administered weekly for one hour by two trained Ph.D. level clinical psychologists with 
extensive experience in addictions treatment and depression. Sessions were audio taped to 
be rated for adherence, and follow up data regarding alcohol intake and depressive 
symptoms collected at one month and three months post termination. Preliminary results 
from this small study indicate that this patient population exists and is willing to seek and 
participate in such extensive and intensive treatment. Below are brief descriptions of the 
course of treatment for two participants in our current study.  
Participant 01, “Denise” is a 54-year-old, Caucasian female who is divorced and lives alone. 
She works full-time as a nurse. At intake, she was diagnosed with Dysthymia, early onset, 
Major Depressive Disorder, recurrent, in partial remission, and Alcohol Dependence. She 
reported that she had been on vacation for three weeks prior to intake and that her 
symptoms of depression and alcohol use had reduced as a result. Denise noted that 
interpersonal stress at work and with family members was a primary trigger for her 
depression. She recognized that she drank to avoid her negative emotions and interpersonal 
problems. At intake, stage of change data indicated that Denise had already begun to reduce 
her alcohol intake and that she was ready to reduce her symptoms of depression. Her stated 
goals for treatment were to learn how to manage her mood so that she no longer used 
alcohol to cope with depression, and to drink at a reduced level because she enjoys the taste 
of alcohol. As shown in Figure 1, at session 1, she was drinking 28 drinks per week and her 
score on the Hamilton Depression Rating Scale was 14. In her final session, she was drinking 
17 drinks per week and her score on the Hamilton Depression Rating Scale was 3. In session 
10, Denise began effectively using Situational Analysis to solve interpersonal problems. As 
can be seen in Figure 1, she continued to practice Situational Analysis using the coping 
survey questionnaire on a weekly basis. By session 16, she reported that she no longer 
needed to drink to manage her mood.  She noted, "For the first time in my life, I am finally 
taking control of situations and facing my demons." Much of her ability to take control of 
situations in her life involved learning through Situational Analysis to set boundaries with 
others. Setting boundaries with others was difficult for her due to fear of interpersonal 
rejection. Her difficulty setting boundaries often caused her to feel taken advantage of by 
others which led to depression and subsequent drinking behavior. Her fear of interpersonal 
rejection was also related to fear of making mistakes. Denise’s transference hypothesis was 
"If I make a mistake with my therapist, I will disappoint her and she will think I am not 
good enough." This fear of interpersonal rejection was addressed in treatment using the 
Interpersonal Discrimination Exercise, and by session 7 the participant was able to 
discriminate between the feedback from the therapist and feedback from significant others 
when she made a mistake. As such, she reported an increased sense of safety and she 
demonstrated an increased ability to assert herself with the therapist. Across the final weeks 
of treatment Denise’s learning generalized and she was regularly setting appropriate 
boundaries with significant others in her life. At termination, the participant stated that she 
no longer felt fear or guilt about expressing her limits to others and setting boundaries.  
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Participant 02, “Paul” is a 45-year-old, Caucasian male who is divorced and lives alone. He 
works part-time as a food vendor and also receives monthly social security disability 
benefits. At intake, he was diagnosed with Major Depressive Disorder, Recurrent and 
Alcohol Dependence. Paul reported an extensive drug and alcohol use history, further 
noting how his substance use helped him to avoid negative emotions and interpersonal 
problems. At intake, stage of change data indicated that he was planning to reduce both his 
alcohol intake and symptoms of depression. His stated goals for treatment were to learn 
how to better manage his mood so that he no longer used alcohol to cope with depression 
(he reported no drug use for the past five years), and to drink at a reduced level because he 
enjoys drinking alcohol. As shown in Figure 1, at session 1, he was drinking 48 drinks per 
week and his score on the Hamilton Depression Rating Scale was 16. In his final session, 
Paul was drinking 15 drinks per week and his score on the Hamilton Depression Rating 
Scale was 3. As can be seen in Figure 1, he continued to practice Situational Analysis using 
the Coping Survey Questionnaire on a weekly basis and began to gain an understanding of 
the importance of communicating to others to achieve socially desirable outcomes. This was 
especially true with regard to expressing negative affect to others. Paul’s transference 
hypothesis was “If I express negative affect, emotions, or feelings to my therapist, then he 
will be angry or upset with me, and reject me.” This fear of interpersonal rejection was 
addressed in treatment using the Interpersonal Discrimination Exercise. Despite the 
participant’s difficulty discriminating between feedback from the therapist and feedback 
from significant others when he expressed negative affect, he reported an increased sense of 
self-confidence to assert himself with the therapist and others. In addition, Paul stated that 
whereas he was more concerned with others’ reactions to his assertiveness in the past, 
across the final weeks of treatment he was more concerned with obtaining socially desirable 
outcomes than with what others’ reactions were to him. 
CBASP has been successfully augmented and implemented with a new and challenging 
patient population in much need of effective treatment options. Although neither patient set 
abstinence as their drinking goal, instead opting to cut back or reduce their alcohol intake to 
a less risky level, they made progress on these goals and remained engaged in treatment. 
Both patients reduced their depressive symptoms dramatically over the course of twenty 
weeks. More importantly, both patients were able to gain insight into the negative impact of 
their transference hypotheses and avoidance behaviors upon their mood and drinking 
behavior, and begin to implement causal thinking to approach and solve interpersonal 
problems. Indeed, preliminary investigations of this pilot study data suggest that treatment 
is most effective when tailored or personalized to the underlying interpersonal issues and 
skill deficits of the patient as presented in the Transference Hypothesis. 
Preliminary results from the research examining CBASP for CDAD outpatients in individual 
therapy are presented in Figures 1, 2, and 3 below, but should be interpreted with caution 
due to the very small sample size (N = 2). However, the results are promising, as both 
participants showed reductions in their drinking measured via the Timeline Followback 
Calendar [69] and depressive symptoms measured via the Hamilton Rating Scale for 
Depression [70], as the number of completed Coping Survey Questionnaires increased. 
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Additional completed study participants are necessary to confirm these preliminary 
findings and additional data collection is underway. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Number of Coping Survey Questionnaires completed, Hamilton Rating Scale for Depression 
scores, and drinks per week by session for Participant 01. Session 0 refers to the participant’s scores at 
baseline. 
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Figure 2. Number of Coping Survey Questionnaires completed, Hamilton Rating Scale for Depression 
scores, and drinks per week by session for Participant 02. Session 0 refers to the participant’s scores at 
baseline. 
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Figure 3. Differences between 90 days pretreatment (blue) and last 90 days in treatment (green) on four 
drinking variables for the study participants. 
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